SCHEMBL6153459

SCHEMBL6153459

CC(C)(C)OC(=O)N1CCCC(Nc2ccc(C(N)=O)cc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.66
NPC1 O15118 2/20 0.65
RAB9A P51151 2/20 0.65
MAPT P10636 1/20 0.65
MAPK1 P28482 1/20 0.65
HTT P42858 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
GPR119 Q8TDV5 4/20 0.61
ABL1 P00519 1/20 0.54
RIN1 Q13671 1/20 0.54
EPHX1 P07099 1/20 0.51
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
PTPN6 P29350 1/20 0.50
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154407 0.95 ALDH1A1 (0.72) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154040 0.91 BTK (0.56) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL18361380 0.89 ALDH1A1 (0.69) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL17832684 0.84 ALDH1A1 (0.73) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL10210061 0.84 ALDH1A1 (0.79) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL23742310 0.84 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL13344251 0.84 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL4243494 0.83 ALDH1A1 (0.76) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154671 0.83 ALDH1A1 (0.50) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154787 0.82 ALDH1A1 (0.61) ALDH1A1NPC1RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 ALDH1A1 2454/4885NPC1 116/4885RAB9A 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.